Myocardial Perfusion Magnetic Resonance Imaging Using Regadenoson

NCT00881218 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Heart Disease

Interventions

DRUG: Regadenoson

Sponsor

Washington University School of Medicine

Collaborators

[object Object]